Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for the Treatment of Central and Ultra-Central Early-Stage Non-Small Cell Lung Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

April 10, 2023

Primary Completion Date

July 28, 2026

Study Completion Date

July 28, 2026

Conditions
Early Stage Non-small Cell Lung CancerNon-small Cell Lung Cancer
Interventions
RADIATION

Computed tomography-guided stereotactic adaptive radiotherapy

Fractions will be delivered on consecutive business days.

DEVICE

ETHOS

ETHOS is a unique ring-gantry CT-guided linear accelerator notable for having an on-board cone beam CT (CBCT) imaging unit with improved definition and resolution to enable target and organ-at-risk contouring. It also has a dedicated artificial intelligence treatment planning system to allow for online adaptive radiotherapy.

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Varian Medical Systems

INDUSTRY

lead

Washington University School of Medicine

OTHER

NCT05785845 - Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for the Treatment of Central and Ultra-Central Early-Stage Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter